BLUE - bluebird bio Stock Trading

bluebird bio Inc.(NASDAQ: BLUE) stock trading, description, contact, officers and directors.

About bluebird bio Inc.

Not available

Stock Information

bluebird bio Inc. Company Name:

BLUE Stock Symbol:

NASDAQ Market:

bluebird bio Inc. Website:

BLUE - bluebird bio Stock Trading

Get BLUE Alerts

News, Short Squeeze, Breakout and More Instantly...

BLUE - bluebird bio Receives EC Approval for SKYSONA(TM) (elivaldogene autotemcel, Lenti-D(TM)) Gene Therapy for Patients Less Than 18 Years of Age With Early Cerebral Adrenoleukodystrophy (CALD) Without Matched Sibling Donor

SKYSONA is the first and only gene therapy approved in the EU to treat early CALD CALD is a rare neurodegenerative disease that can lead to progressive, irreversible loss of neurologic function, and death One-time treatment with SKYSONA has been shown to have a durable...
BLUE - bluebird bio Announces Positive Recommendation by PRAC Regarding Article 20 Safety Referral Review of ZYNTEGLO(TM) Gene Therapy for Transfusion-Dependent ?-thalassemia and Marketing to Resume in EU

EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) confirms favorable benefit-risk balance of ZYNTEGLO Company has informed EMA of lift of voluntary temporary marketing suspension bluebird bio, Inc . (Nasdaq: BLUE) today announced that the Europe...
BLUE - Will This 2020 Biotech IPO Crush the Market This Year?

Cutting-edge pharma Legend Biotech (NASDAQ: LEGN) burst onto the scene at the 2017 American Society of Clinical Oncology (ASCO) meeting with fantastic early clinical trial results for its multiple myeloma treatment. Now, with even better data in hand after ASCO 2021, the company and...